Dr Michael O’Neill, director of research and development at Inflection Biosciences, Darren Cunningham, chief executive at Inflection and Prof Bryan Hennessy, senior clinical lecturer at RCSI and consultant medical oncologist. Photograph: Julien Behal

Irish drug development company Inflection Biosciences will present data on its fledgling breakthrough breast cancer therapy to the American Associatio(...)